Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 771-780 of 2858 for cancer

Edit search filters
  1. A Study To Evaluate The Da Vinci® Xi™ Surgical System In Nipple Sparing Mastectomy (NSM) Procedures

    Jacksonville, FL, Rochester, MN

  2. Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study To Evaluate The Safety Of HANAROSTENT® Biliary Flap Lasso Stent System Use To Treat Cancer Patients With Biliary Obstruction

    Rochester, MN

  4. Pivotal Study Of The NanoKnife System For The Ablation Of Prostate Tissue

    Rochester, MN

  5. Advancing Skin Cancer Prevention And Treatment Through DNA Repair Enzymes: A Clinical Approach In Solid Organ Transplant Recipients

    Jacksonville, FL

  6. Ease Aromatase Inhibitor-induced Musculoskeletal Symptoms

    Rochester, MN

  7. PERT For Treatment Of Exocrine Pancreatic Insufficiency In Patients With Unresectable Pancreatic Cancer

    Jacksonville, FL

  8. A Study Of SC-006 In Subjects With Advanced Cancer

    Rochester, MN

  9. BCL2 Inhibitor Venetoclax With Daratumumab-Lenalidomide-Dexamethasone Or Venetoclax-Rd For Newly Diagnosed Multiple Myeloma

    Rochester, MN

  10. Individualized Treatment In Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based On EBV DNA

    Rochester, MN

.

Mayo Clinic Footer